This report captures the dosage wise monthly change in drug pricing in the US generics market.
US generic drug pricing is a significant variable determining the lucrativeness of the market.
The report covers only US generic drugs and captures its Month-on-Month price change for the last 12 month for various dosage forms.
The price reflects NADAC pricing as reported by Centre for Medicare and Medicaid Studies.
The report offers a graphical view of aggregate M-o-M price changes for last 12 months in generic drugs for various dosage forms like Orals, Injectables, Inhalation, Ophthalmic, Topicals, Transdermal and Dental drugs.